CXCL10 and cystic fibrosis: Intermediately elevated IP-10 levels were also observed in the BALF of disease controls (267 pg/mL [36,1968], N=20, P=0.05 post-lung transplant controls), suggesting IP-10 may not be unique to CF APE.